Demant A/S (DEMANT.CO) stock: key figures, P/E, revenue and dividend
Health Care · Denmark · ISIN DK0060738599
Demant A/S financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 22.42 bn DKK | 23.08 bn DKK |
| Gross profit | 17.09 bn DKK | 16.11 bn DKK |
| Operating income | 4.71 bn DKK | 4.06 bn DKK |
| Net income | 2.39 bn DKK | 1.55 bn DKK |
| Diluted EPS – continuing operations | 13.31 DKK | 11.20 DKK |
Full history since 2002, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Demant A/S
Demant A/S operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally. It engages in the development, manufacture, and wholesale of hearing aids; owning and operating hearing care clinics; and offers hearing and balance assessment solutions used by audiologists, ENT doctors, and balance clinics. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.
More stocks
- Yamaha Motor Co Ltd (7272.T)
- Smiths Group PLC (SMIN.L)
- Deckers Brands (DECK)
- Swatch Group AG (UHR.SW)
- HUBSPOT INC (HUBS)
- Rexel SA (RXL.PA)
- Akzo Nobel NV (AKZA.AS)
- Focus Media Information Technology Co Ltd (002027.SZ)
- UDR, Inc. (UDR)
- Freedom Holding Corp. (FRHC)
- Samsung Fire And Marine Ins Pref (000815.KS)
- Saputo Inc (SAP.TO)
Not investment advice. All data without warranty, price as of 14.10.2026. Details in the risk notice.